🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06675461
Enrolling by invitation Not applicable

Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency Department

NCT06675461 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-12-12
Last updated
2026-02-11

Condition(s) studied

Borderline Personality Disorder (BPD)

Investigational drug(s) / intervention(s)

Gold Card InterventionTreatment as usual

Gold Card Intervention: A 4-session manualized intervention consisting of weekly scheduled 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support.

Treatment as usual: Access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.

Study summary

When in crisis, people with borderline personality disorder (BPD) frequently seek care in emergency departments (EDs) often presenting with suicide and self-harm behaviour. There is no established evidence-based brief treatment for patients with BPD in ED settings, however a 4-session treatment for people with personality disorders in ED settings was tested in Australia and showed promising results in reducing health care use and improving symptoms. A recent pilot feasibility randomized controlled trial (RCT) comparing this 4-session treatment to treatment as usual was conducted at the Centre for Addiction and Mental Health and preliminary findings have shown that the treatment is feasible to deliver and acceptable to both patients and clinicians. The proposed fully powered RCT will build on this pilot data to assess the efficacy of delivering this 4-session intervention in the ED for people with BPD who present with suicidal ideation or self-harm with the aim of reducing emergency health care use and improving BPD symptoms, functioning and quality of life.

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Must be deemed to have capacity to provide informed consent; 2. Must sign and date the informed consent form; 3. Stated willingness to comply with all study procedures; 4. Aged 16 or older; 5. Presenting to ED with self-harm and/or suicidal ideation; 6. Meeting criteria for BPD on the International Personality Disorders Examination (IPDE). 7. Endorsing a score of 1 or greater on the Suicide Ideation Attributes Scale (SIDAS). Exclusion Criteria: 1. Meeting DSM-5 criteria for schizophrenia spectrum disorder or bipolar disorder I mania based on the Structured Clinical Interview for DSM-5 (SCID-5); 2. Severe alcohol or substance use disorder based on the Structured Clinical Interview for DSM-5 (SCID-5) requiring medical detoxification or residential treatment. 3. IQ \< 70 based on the Test of Premorbid Functioning (TOPF).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre for Addiction and Mental Health Toronto Ontario

More Centre for Addiction and Mental Health trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06675461 on ClinicalTrials.gov ↗ ← All trials in Canada